Wuyan Pang

机构：Henan University Huaihe Hospital and Huaihe Clinical Institute · ORCID：0000-0003-1691-0060

发表论文 33 篇 · 总被引 580 次 · h-index 10

代表论文

• Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway (2018 · Biological Research · 被引 204)
• VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients (2018 · CHEST Journal · 被引 103)
• Inonotus sanghuang Polyphenols Attenuate Inflammatory Response Via Modulating the Crosstalk Between Macrophages and Adipocytes (2019 · Frontiers in Immunology · 被引 32)
• Improved glycaemic control and weight benefit with iGlarLixi versus insulin glargine 100 U/ mL in Chinese people with type 2 diabetes advancing their therapy from basal insulin plus oral antihyperglycaemic drugs: Results from the LixiLan‐L‐CN randomized controlled trial (2022 · Diabetes Obesity and Metabolism · 被引 28)
• Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial (2024 · Diabetologia · 被引 22)
• Inhibition of miR-324-5p increases PM20D1-mediated white and brown adipose loss and reduces body weight in juvenile mice (2019 · European Journal of Pharmacology · 被引 18)